Cholestello®, a Cholesterol Aid Created by Health Technology Firm Psigryph Inc., To Make United States Debut

Psigryph Incorporated, a Canadian-based company focused on redefining the way we deliver bioactive molecules across the cell membrane, is excited to announce the United States release of a new health supplement called Cholestello®.

Cholestello is a nutrient-dense food powder that is designed to help people maintain healthy cholesterol levels, and it is intended to be used alongside a cholesterol management plan. In animal studies, Cholestello was shown to support healthy cholesterol levels, thus helping to prevent health problems caused by high cholesterol.

Using an all natural ingredient blend, Cholestello works by utilizing a patented technology called Nanopect® that is owned by Psigryph Inc. This unique technology allows the body to absorb nutrients more efficiently, meaning smaller amounts need to be consumed to see a positive impact.

“High cholesterol is a health issue we know impacts millions of people, and our team at Psigryph wanted to help those struggling by giving them a more natural, consumer-friendly solution,” said CEO Sean Thompson. “Statins are incredible drugs, but they don’t help everyone. We knew another solution was needed, and we’re excited for people to experience the power and benefits of Cholestello in the near future.”

To learn more about Psigryph Incorporated, visit https://www.psigryph.com/.

More On Psigryph Incorporated: 

Led by CEO Sean Thompson and headquartered in Guelph, Ontario, Psigryph Inc. aims to improve the health of humans across the globe through the creation of natural products. Utilizing a patented technology called Nanopect, Psigryph Inc.’s products deliver an incredible number of molecules across the body’s cell membranes, increasing bioavailability.

Psigryph Inc. was founded in 2018 by Sean Thompson and the late Indo-Canadian biochemist Dr. Gopinadhan Paliyath. Paliyath’s mission was to increase western consumption of natural products with known health benefits. While Paliyath unfortunately passed away in 2022, his work is being continued by Thompson as well as Paliyath’s son Vas (head of product manufacturing and marketing). Thompson has over 20 years of pharmaceutical research experience and aims to create consumer-friendly products that change the modern medical landscape. Thompson was also a finalist in the 2023 CanadianSME Small Business Awards for the category of Black Entrepreneur of the Year.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. This press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press release is not associated with InHealthMedia. It is merely publishing a press release announcement submitted by a company, without any stated or implied endorsement of the product or service.

About InHealth Media

InHealth Media knows how to put press releases in front of the right purchasers and consumers. We use proprietary software wire services, target audience email blasts, have an in-depth knowledge of SEO and create captivating story angles that appeal to a spectrum of readers as well as major retailers and buyers.